The complete absence of leptin causes severe obesity in mice and humans, but its physiological roles are incompletely defined. Earlier studies reported decreased brain weight and impaired myelination in ob/ob and db/db mice. Here we have examined the effects of leptin deficiency and postnatal leptin treatment on brain weight, the expression of a broad array of neuronal and glial markers, and locomotor activity. ob/ob and db/db mice have reduced brain weight and an immature pattern of expression of synaptic and glial proteins, with growth-associated protein being elevated in the neocortex and hippocampus, and syntaxin-1, synaptosomal-associated protein-25, and synaptobrevin being decreased. The expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein was also decreased in the neocortex, hippocampus, and striatum of ob/ob and db/db mice. Six weeks of leptin treatment initiated at week 4 increased brain weight and protein content, increased locomotor activity, and normalized levels of growth-associated protein, syntaxin-1, and synaptosomal-associated protein-25 in ob/ob mice without affecting synaptobrevin and glial proteins. In contrast with ob/ob and db/db mice, obese agouti (A y /a) mice had normal brain weight and expression of synaptic and glial proteins. These findings suggest that leptin, a peripheral signal of energy stores in adult animals, is required for normal neuronal and glial maturation in the mouse nervous system. (Endocrinology 140: [2755][2756][2757][2758][2759][2760][2761][2762] 1999) T HE ADIPOSE hormone leptin is thought to regulate feeding, thermogenesis, and neuroendocrine function by acting on neuronal targets in the hypothalamus (reviewed in Refs. 1-3). However, studies suggest that leptin has more widespread actions in the central nervous system. Leptin deficiency leads to reduced brain weight, structural neuronal abnormalities, decreased brain DNA content, and impaired myelination in ob/ob mice (4 -8). A broader role of leptin in development is also suggested by its capacity to influence the onset of puberty (9, 10) and recent evidence that its levels rise in neonatal mice and may regulate the postnatal development of the neuroendocrine axis (11, 12). Furthermore, there appears to be a dose effect of leptin action during postnatal development, such that lower levels of leptin are required for maturation of the neuroendocrine axis (13). In contrast, expression of leptin within the physiological range during the prenatal period prevents hyperphagia, but does not ameliorate thermoregulatory abnormalities in ob/ob mice (13).
T HE ADIPOSE hormone leptin is thought to regulate feeding, thermogenesis, and neuroendocrine function by acting on neuronal targets in the hypothalamus (reviewed in Refs. [1] [2] [3] . However, studies suggest that leptin has more widespread actions in the central nervous system. Leptin deficiency leads to reduced brain weight, structural neuronal abnormalities, decreased brain DNA content, and impaired myelination in ob/ob mice (4 -8) . A broader role of leptin in development is also suggested by its capacity to influence the onset of puberty (9, 10) and recent evidence that its levels rise in neonatal mice and may regulate the postnatal development of the neuroendocrine axis (11, 12) . Furthermore, there appears to be a dose effect of leptin action during postnatal development, such that lower levels of leptin are required for maturation of the neuroendocrine axis (13) . In contrast, expression of leptin within the physiological range during the prenatal period prevents hyperphagia, but does not ameliorate thermoregulatory abnormalities in ob/ob mice (13) .
Leptin administration prevents hyperphagia and obesity and restores neuroendocrine function in adult ob/ob mice (reviewed in Refs. [1] [2] [3] , therefore implying that the brain is capable of responding to leptin during the postnatal period. To test the hypothesis that leptin influences brain development, we compared the expression of several neuronal and glial proteins among ob/ob, db/db, and leptin-resistant agouti (A y /a) mice. We show that leptin deficiency or insensitivity to its action leads to decreased brain weight and protein content, elevated levels of growth-associated protein (GAP- 43) , and a reduction in the expression of several synaptic and glial proteins in the forebrains of ob/ob and db/db mice. Postnatal leptin administration increased brain weight, whole brain protein content, syntaxin-1, and synaptosomal-associated protein (SNAP-25) and decreased GAP-43 levels in ob/ob mice.
Locomotor activity, which was markedly reduced in ob/ob mice, was improved by leptin treatment. These findings are consistent with the view that leptin has diverse modulatory actions in the central nervous system in addition to its well known effects on energy homeostasis. Regulation of brain development by leptin may have important implications for the establishment of neural pathways for feeding, autonomic regulation and neuroendocrine function, and mechanisms linking impaired nutrition during the neonatal period with neural development.
Materials and Methods

Animals and treatment
Female C57BL/6J ob/ob and db/db mice, aged 4 -20 weeks, agouti (A y /a) mice, aged 6 -20 weeks, and their lean littermates (The Jackson Laboratory, Bar Harbor, ME) were housed in groups of eight per cage under a 12-h light (0600 -1800 h), 12-h dark (1800 -0600 h) cycle and controlled temperature (ϳ22 C) and humidity (30 -35%) and were allowed ad libitum access to chow and water. The experimental protocol was in accordance with guidelines of the animal care and use committee of the Beth Israel Deaconess Medical Center and Harvard Medical School.
ob/ob and db/db mice received daily ip injections of recombinant murine leptin (Eli Lilly & Co., Indianapolis, IN) at a dose of 1 g/g BW in 100 l saline or vehicle alone starting from age 4 and 8 weeks, respec-tively, until age 10 weeks. Lean littermates were injected with saline. Body weight was measured daily, and the dose of leptin was adjusted every third day. Injections were performed between 0800 -1000 h of the light cycle. To determine whether leptin's effects were mediated indirectly by an increase in thyroxine (T 4 ) and a decrease in glucocorticoids during the postnatal period (12, 13) , groups of 4-and 8-week-old ob/ob and db/db mice were injected daily with 1 g l-T 4 for 2 weeks or with 2 g/g RU486 (14, 15) . Treatment with RU486 or a combination of RU486 and l-T 4 was discontinued after 1 week because of increased mortality.
Effect of leptin on hormone levels and synaptic and glial proteins
Groups of mice were killed at various ages by rapid carbon dioxide inhalation, and corticosterone, T 4 , insulin and leptin were measured by RIA (12, 16) . Plasma glucose was measured with a glucose oxidase assay (Sigma Chemical Co., St. Louis, MO). Brains were weighed, and the neocortex, hippocampus, striatum, hypothalamus, cerebellum, and brain stem were dissected, frozen rapidly in liquid nitrogen, and stored at Ϫ80 C. Brain homogenates and membrane-enriched fractions were prepared (17, 18) , and protein concentration was measured using a Bio-Rad DC Protein Assay kit (Bio-Rad Laboratories, Inc., Hercules, CA).
For synaptic proteins and glial fibrillary acidic protein (GFAP), 5-to 10-g protein aliquots were electrophoresed in 10% SDS-polyacrylamide gels and transferred to nitrocellulose. Western blotting was carried out with specific antibodies, and proteins were detected with peroxidase-conjugated secondary antibodies and enhanced chemiluminescence (Amersham, Arlington Heights, IL). Antibodies were obtained from Sigma Chemical Co. (St. Louis, MO), Chemicon (Temecula, CA), and Transduction Laboratories, Inc. (Lexington, KY) and were used at the following dilutions: GAP-43, 1:4000; syntaxin-1/HPC1, 1:2000; SNAP-25, 1:1000; synaptophysin, 1:3000; synaptotagmin, 1:2000; synaptobrevin, 1:3000; and GFAP, 1:1000. Myelin proteins were extracted as described previously (19, 20) , separated by electrophoresis on 15% SDSpolyacrylamide gels, and detected by Western blotting. Specific antibodies to myelin basic protein (MBP), proteolipid protein (PLP), and 2Ј,3Ј-cyclic nucleotide 3Ј-phosphohydrolase (CNP) were obtained from Chemicon and were used at dilutions of 1:2500, 1:1000, and 1:500, respectively.
The relative abundance of synaptic and glial proteins was measured by laser densitometry of autoradiograms (Molecular Dynamics, Inc., Sunnyvale, CA). Integrated densities of the following protein bands recognized by specific antibodies were measured and taken to represent the relative quantities of the respective proteins: GAP-43 (43 kDa), syntaxin-1 (35 kDa), synaptophysin (38 kDa), SNAP-25 (25 kDa), synaptobrevin (18 kDa), synaptotagmin (65 kDa), GFAP (50 kDa), MBP (21 kDa), PLP (25 kDa), and CNP (48 kDa). A linear relationship with r values ranging from 0.9 -0.95 was established between the density of immunostained bands for respective proteins and sample protein values between 5-30 g (data not shown). Immunoblot analysis revealed similar levels of synaptophysin levels within specific brain regions in wild-type and mutant mice. Moreover, synaptophysin levels did not change with age (4 -10 weeks) or leptin treatment and were therefore useful as an internal control for protein loading. The effect of leptin on the levels of GAP-43 and synaptic and glial proteins was determined by ANOVA and Fisher protected least protected difference test; P Ͻ 0.05 was considered significant.
Morphological studies
Adult ob/ob, db/db, and wild-type mice, aged 10 and 20 weeks, respectively (n ϭ 3/group), were deeply anesthetized with ip sodium pentobarbital injection and perfused transcardially with PBS, followed by 10% neutral buffered formalin. Brains were allowed to remain in the skull for 2 h and then were immersed in the same fixative at 4 C for 3 days. After cryoprotection in 10% PBS-sucrose, 40-m coronal sections were cut on a sliding microtome and processed for silver staining (21) (FD Neurotechnologies, Elicott City, MD). Adjacent sections were stained with thionin. The sections were examined under brightfield optics using a Zeiss Axioskop microscope (Carl Zeiss, New York, NY). Neurons undergoing degeneration appeared black, whereas normal neurons appeared golden yellow.
Brain sections corresponding to bregma levels Ϫ1.46 and Ϫ1.82 mm, i.e. Figs. 43 and 46 in the atlas of Paxinos and Franklin (22) , were selected, matched, and analyzed by an observer blinded to the experiment. Silverstained (black) cells were counted with a grid reticule and ϫ10 objective lens in the parietal cortex and hippocampus in each hemisphere, and average counts per region were determined. Statistical differences between groups were analyzed by t test; P Ͻ 0.05 was considered significant.
Behavior observation
Locomotor activity in a novel environment was assessed with an open field test (23) . Testing was carried out between 1300 -1500 h in three clear plastic cages, with dimensions of 45 cm ϫ 24 cm ϫ 22 cm containing a paper floor grid, by an observer who was blinded to the treatment protocol. The mice were placed simultaneously in individual cages, and after allowing 1 min for acclimation, they were observed sequentially for 1-min periods for a total of 10 observations/test session. Mice were scored for walking (i.e. number of floor grid lines crossed), climbing, rearing, and grooming. Locomotor activity was defined as the sum of the above behaviors during the test period. After measuring baseline activity, ob/ob mice received daily ip injections of leptin (1 g/g BW) or saline starting from 4 weeks of age. Lean littermates were injected with saline. Exploratory behavior was measured weekly in age-matched saline-and leptin-treated mice. The potential interaction between obesity and exploratory behavior was assessed further by comparing activity scores between obese A y /a mice and their lean littermates. The effects of leptin on body weight and locomotor activity in ob/ob mice were determined by ANOVA and Fisher's protected least significant difference test. Differences in body weight and locomotor activity between obese A y /a mice and lean controls were analyzed by t test; P Ͻ 0.05 was considered significant. trend toward lower T 4 levels in ob/ob and db/db mice compared with lean littermates, the difference was not statistically significant. Corticosterone and T 4 levels were normal in A y /a mice. There was a significant reduction in wet brain weight by about 5% from 378 Ϯ 3.8 to 354 Ϯ 3.0 mg in 4-week-old ob/ob mice compared with that in wild-type littermates (P ϭ 0.04) and by 20% in 10-week-old ob/ob mice ( Table 1 ). The total brain protein content was 10% lower in 4-week-old ob/ob mice (46.5 Ϯ 2.5 mg) compared with that in wild-type mice (41.5 Ϯ 1.5 mg; P ϭ 0.03). There was a significant decrease in brain protein content by 14% in 10-week-old ob/ob mice (Table 1) . Six weeks of leptin treatment initiated at age 4 weeks resulted in a significant increase in brain weight and total protein content in ob/ob mice (Table 2 ). However, leptin treatment for up to 2 weeks did not alter brain weight or total protein content when initiated in 8-week-old ob/ob mice ( Table 2 ). Brain weight and protein content were significantly reduced at 4 weeks (data not shown) and 10 weeks in db/db mice ( Table 1) . Leptin treatment initiated at either 4 or 8 weeks did not affect brain weight and protein content in db/db mice. There was no difference in brain weight and total protein concentration between A y /a and wild-type mice (Table 1) . To determine the possible role of neurodegeneration in the reduction of brain weight in ob/ob and db/db mice, brain sections were stained to detect neuronal silver accumulation. Numerous argyrophyllic neurons were observed in the frontoparietal cortex, especially layers IV and V, as well as in the granule cell layer of the dentate gyrus and CA3 of the hippocampus in ob/ob and db/db mice. The number of silverstained cells was 6-fold higher in the parietal cortex of 10-week-old ob/ob and db/db mice (23.8 Ϯ 4.0 in ob/ob mice and 19.8 Ϯ 4.8 in db/db mice compared with 2.8 Ϯ 0.5 in wild-type mice; P Ͻ 0.01). The number of silver-stained cells was significantly higher in the granule cell layer of the dentate gyrus in 10-week-old ob/ob mice (12.5 Ϯ 2.3) and db/db mice (10.6 Ϯ 1.8) compared with that in wild-type littermates (1.8 Ϯ 1.0). A similar distribution of silver-stained cells was observed in the neocortex (Fig. 1) and hippocampus of 20-week-old ob/ob ( Fig. 1) and db/db (micrograph not shown) mice. The number of silver-stained cells did not change significantly from 10 -20 weeks of age or in response to leptin treatment.
Results
Effect of leptin on hormone levels, brain weight, and protein content
Regulation of GAP-43 and synaptic proteins by leptin
We examined changes in the expression of GAP-43 and synaptic proteins in 4-, 8-, and 10-week-old mice by immunoblot analyses of brain homogenates. There was no difference in the levels of GAP-43 and synaptic proteins in the neocortex (Fig. 2 ) and other brain regions between A y /a and wild-type mice. In contrast, expression of GAP-43 and synaptic proteins was differentially regulated by leptin in ob/ob and db/db mice (Figs. 2-4 ). GAP-43 was elevated 3-fold in the neocortex (Fig. 3A) , striatum, and hippocampus (data not shown) of ob/ob and db/db mice. Daily leptin injection at a dose of 1 g/g BW initiated at 4 weeks decreased GAP-43 expression in the neocortex (Figs. 3A and 4A) , hippocampus, and striatum of ob/ob mice, but did not affect GAP-43 levels in db/db mice (Fig. 3A) .
There was an age-dependent decrease in the expression of syntaxin-1, SNAP-25, and synaptobrevin in the neocortex (Fig. 3, B-D) , hippocampus, and hypothalamus of ob/ob mice. For example, syntaxin-1, SNAP-25, and synaptobrevin were reduced significantly by 10 -30% in the neocortex of 4-weekold ob/ob mice and decreased further to 20 -40% of control levels by age 10 weeks (Fig. 3, B-D) . Leptin treatment restored syntaxin 1 (Figs. 3B and 4C ) and SNAP-25 ( Fig. 3C ), but did not affect synaptobrevin (Fig. 3D) . Expression of syntaxin-1, SNAP-25, and synaptobrevin was also decreased in the neocortex (Figs. 2B and 3, B-D) , hippocampus, and hypothalamus of db/db mice and was not altered by age or leptin treatment. Synaptophysin and synaptotagmin levels were normal in ob/ob and db/db mice (Figs. 2C, 3 , E and F, and 4D).
Regulation of glial proteins by leptin
There was no difference in the expression of glial proteins between A y /a and wild-type mice (data not shown). Furthermore, the expression of glial proteins did not change with age (4 -10 weeks) in wild-type and mutant mice (data not shown). Figures 4 and 5 illustrate the effects of leptin deficiency and leptin treatment on glial proteins. GFAP, MBP, and PLP were reduced in the neocortex (Fig. 5, A and C) , striatum (Fig. 5B) , and hippocampus of ob/ob and db/db mice. There was normal expression of the 21-kDa isoform of MBP in cerebellar (Fig. 5A ) and brain stem extracts from ob/ob and db/db mice; however, a 35-kDa band that was localized in wild-type mice was clearly deficient in the cerebellum of ob/ob and db/db mice (Fig. 5A ). GFAP and PLP levels were normal in the cerebellum and brain stem (data not shown).
Unlike structural myelin proteins, levels of the myelinassociated enzyme CNP were not altered in the neocortex (Fig. 5C ) and other brain regions. Daily leptin treatment from 4 -10 weeks of age did not affect GFAP and myelin proteins in ob/ob (Fig. 5, B and C) and db/db mice. As glucocorticoids and thyroid hormone are regulated by leptin (12, 13, 16 ) and, in turn, regulate the synthesis of glial proteins (19, 20, 24 -26) , we determined the effect of T 4 treatment and/or glucocorticoid blockade on GFAP and myelin proteins in ob/ob and db/db mice. Although serum T 4 levels rose to 8 -12 g/dl after 2 weeks of treatment in 4-week-old ob/ob mice, myelin proteins and GFAP were not altered. Similarly, blockade of glucocorticoids with RU486 from 4 -5 weeks of age did not affect glial proteins (data not shown).
Effect of leptin on locomotor activity
Locomotor activity was decreased in ob/ob mice at all ages compared with that in lean controls (Fig. 6, A and B) . Of the four behavioral parameters examined, walking, climbing, and rearing were the most affected by leptin deficiency. Locomotor activity was 50% lower in 4-week-old ob/ob mice compared with that in lean littermates. There was no further reduction in activity in ob/ob mice within the first week (4 -5 weeks of age) despite an increase in body weight by 25% (P Ͻ 0.05). However, by age 10 weeks body weight had increased by 80%, whereas locomotor activity decreased by 50%. Prevention of weight gain in ob/ob mice by daily leptin injection resulted in an increase in locomotor activity by 70% within 1 week of initiation of treatment (Fig. 6, A and B) . In contrast with that in ob/ob mice, locomotor activity was not affected by obesity in A y /a mice (Fig. 6C ).
Discussion
Hyperphagia, impaired thermoregulation, morbid obesity, central hypogonadism, hypothyroidism, and hypercortisolism in ob/ob and db/db mice are consistent with a hypothalamic disorder (1, 2, 27) ; however, the observations in this study regarding abnormalities of brain weight and neuronal and glial proteins in ob/ob mice and db/db mice support a more widespread action of leptin in the central nervous system. Structural and biochemical defects such as smaller neuronal size, abnormal dendritic orientation, lower DNA content, abnormal myelination, and widespread neurotransmitter derangement in the brains of ob/ob mice are well documented (4 -8) ; however, the factors that predispose to these abnormalities are not known. Decreased brain weight in ob/ob and db/db mice could result from a reduction in the number of neurons and glia, decreased myelination, and a reduction in water content. Previous studies have demonstrated a decrease in both wet and dry brain weights in ob/ob and db/db mice (8, 28) ; therefore, differences in water content are unlikely to account for the reduction in brain weight observed in the present study. The observation that ob/ob and db/db mice have increased neuronal silver accumulation in the neocortex and hippocampus compared with lean littermates is consistent with an earlier onset of neurodegeneration and suggests that the reductions in cerebral cortical volume, brain weight, and DNA content described previously (4 -8) could be partly due to neuronal loss.
FIG. 2. Comparison of immunoblots of GAP-43 (A)
, syntaxin-1 (B), and synaptophysin (C) in neocortical extracts of 10-week-old ob/ob, db/db, agouti (Ay/a), and wild-type C57BL/6 and C57BL/ks mice. Note the increased expression of GAP-43 and the reduction in syntaxin-1 in ob/ob and db/db mice. Synaptophysin levels were unchanged in mutant mice.
Development of the central nervous system is influenced by hormones during the postnatal period. For example, glucocorticoids regulate neuronal and glial proliferation and differentiation, whereas thyroid hormone and GH regulate several aspects of postnatal brain development, notably myelination (19, 20, 24 -26) . The widespread distribution of leptin targets in the brain and localization of leptin receptors in neurons as well as glia (29 -31) is suggestive of direct regulation of neuronal and glial function by leptin. On the other hand, as leptin regulates the levels of glucocorticoids, thyroid hormone, and GH (12, 13, 16, 32) , and these hormones are known to influence brain development (19, 20, 24 -26) , it is possible that the observed differences in the levels of neuronal and glial proteins between ob/ob and lean mice are at least in part an indirect result of leptin deficiency.
ob/ob and db/db mice had an immature pattern of expression of GAP-43 and components of the SNARE synaptic transport complex (33) (34) (35) . GAP-43 is expressed at high levels during neonatal life and has been implicated in axogenesis (33, 34) . There is marked reduction in GAP-43 after weaning; however, low levels persist in several brain regions in the adult brain and may play a role in synaptic plasticity (33, 34) . ob/ob and db/db mice had elevated levels of GAP-43 and reductions in syntaxin-1, SNAP-25, and synaptobrevin. Leptin treatment normalized GAP-43, syntaxin-1, and SNAP-25 levels in ob/ob mice.
The functional implications of differential regulation of synaptic proteins by leptin are not known. As the level of synaptic proteins is likely to influence synaptic activity and hence neurotransmitter release, we speculate that abnormalities of synaptic transmission resulting from leptin deficiency may contribute to the complex and widespread central nervous system dysfunction observed in ob/ob mice. The discovery that leptin regulates neuropeptide Y release from brain slices through a calcium-dependent pathway supports of a role for leptin in synaptic transmission (36) . Results from the current study showing a decrease in locomotor activity in ob/ob mice are in agreement with classic studies by Joosten and van der Kroon (37) . Several lines of evidence argue against the idea that ob/ob mice are less active because they are morbidly obese. First, other genetically obese mice, e.g. agouti (A y /a and A vy /a) and New Zealand obese (NZO) mice, are as active as their lean littermates (38) . Second, decreased locomotor activity precedes the onset of morbid obesity in ob/ob mice (37, 39) . Third, studies by Clark and Gay (40) have shown that ob/ob mice are less active than weight-matched normal mice. Although the improvement in locomotor activity as a result of leptin administration could be attributed in part to weight loss, it is conceivable that normalization of synaptic proteins levels in the neocortex and hippocampus by leptin may have enhanced locomotor activity by increasing motivational and other higher aspects of behavior. This hypothesis awaits further experimentation.
Leptin deficiency resulted in decreased levels of myelin proteins and GFAP in the forebrain of ob/ob mice. This finding is in agreement with previous studies showing decreased brain myelin content as well as abnormal myelin lipid composition in ob/ob mice (4, 8, 41) . Abnormalities of myelinassociated enzymes have also been described in db/db mice (28) . Our observation that levels of the myelin enzyme CNP are unchanged in ob/ob mice despite a marked reduction in brain myelin content is in agreement with a previous report (8) , and supports the view that leptin deficiency affects myelin synthesis. The failure of leptin treatment initiated at age 4 weeks to increase myelin proteins and GFAP in ob/ob mice is not inconsistent with the regulation of glial proteins by leptin. Other metabolic hormones, such as glucocorticoids and thyroid hormone, influence brain maturation at different stages of development (26) . For example, myelin proteins are decreased by thyroidectomy during the second postnatal week, but not in older mice (19) . Thyroid hormone regulates the expression of myelin proteins at an earlier stage in the hindbrain of neonatal rodents compared with that in forebrain regions such as the striatum and neocortex (19, 20) . Similarly, the phenotype of ob/ob mice, including decreased brain weight, is regulated by glucocorticoids during the postnatal period (42) . Adrenalectomy at 4 -5 weeks of age prevents the development of morbid obesity as well as a reduction in brain weight in ob/ob mice (42) . The failure of daily injections of leptin, T 4 , and glucocorticoid blockade to normalize myelin proteins and GFAP in 4-week-old ob/ob mice could be explained by either the late timing or the short duration of treatment.
There are similarities between the phenotype of leptindeficient and insensitive rodents and humans, such as hyperphagia, morbid obesity, decreased linear growth, central hypogonadism and hypothyroidism, and impaired sympathetic response (1, 27, (43) (44) (45) . However, the limited data to date suggest that leptin deficiency does not lead to hypercortisolism in humans, and brain structure is reported to be normal on computerized tomography (44) . Leptin deficiency causes compulsive eating in humans, but has not as yet been associated with psychomotor or learning abnormalities (43) (44) (45) . The mechanisms underlying the species differences in the hypothalamic-pituitary-adrenal axis and brain morphology between leptin-deficient rodents and humans have yet to be determined and are important subjects for future research.
A role of leptin in development is further suggested by the expression of leptin by placenta (46, 47) , widespread synthesis of leptin and leptin receptors in fetal tissues (47) , and regulation of hemopoiesis by leptin (48) . The ability of leptin to regulate brain weight, brain protein content, and several neuronal and glial markers supports the view that leptin is of fundamental importance to brain maturation at least in rodents. As with other metabolic hormones, leptin is likely to influence brain development at critical stages of the prenatal and early postnatal periods. A potential developmental role of leptin may be to serve as an important link between early nutrition and brain development. 
